Multiple system atrophy, or MSA, is a rare neurodegenerative disorder with symptoms akin to ALS or Parkinson’s disease in the ...

The FDA has approved Zevra Therapeutics' Miplyffa (arimoclomol) as the first treatment for neurological symptoms of ...

From breakfast to dinner, ultra-processed foods are everywhere. They're the quick and easy fix we all crave, but are they ...

To address the unmet need for a cure for RTT, the therapeutic potential of adult Neural Precursor Cells (NPCs) was ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients' quality of life over time. It causes neuropsychiatric disorders and ...

Alzheimer's disease, a devastating neurodegenerative condition that affects millions of people worldwide, may have found a ...

Microplastic has been detected in the human brain’s smell centre for the first time in a new study, suggesting that the ...

Many of the risk factors for dementia – being female, growing older and the genetic lottery — cannot be avoided. But research is uncovering a growing list of ways to cut your risk.

A cortical tri-culture model advances the validation process in neurodegenerative drug discovery, offering new possibilities ...